What is the current valuation of the India radiopharmaceuticals market?

As of 2024, the India radiopharmaceuticals market was valued at 0.443 USD Billion. Read More

What is the projected market size for the India radiopharmaceuticals market by 2035?

The market is expected to reach a valuation of 1.06 USD Billion by 2035. Read More

What is the expected CAGR for the India radiopharmaceuticals market during the forecast period 2025 - 2035?

The anticipated CAGR for the market during the 2025 - 2035 period is 8.26%. Read More

Which application segment is projected to have the highest growth in the India radiopharmaceuticals market?

The oncology application segment is projected to grow from 0.175 USD Billion to 0.4 USD Billion by 2035. Read More

What are the key end-use segments in the India radiopharmaceuticals market?

Key end-use segments include hospitals, diagnostic centers, research institutions, and pharmaceutical companies. Read More

How much is the hospitals segment expected to grow by 2035?

The hospitals segment is expected to increase from 0.1772 USD Billion to 0.4156 USD Billion by 2035. Read More

What types of radiopharmaceuticals are included in the market analysis?

The market analysis includes diagnostic radiopharmaceuticals, therapeutic radiopharmaceuticals, radioisotopes, and radiopharmaceutical generators. Read More

Which distribution channel is projected to see significant growth in the India radiopharmaceuticals market?

The online sales distribution channel is expected to grow from 0.0886 USD Billion to 0.243 USD Billion by 2035. Read More

What are the leading companies in the India radiopharmaceuticals market?

Key players include Bhabha Atomic Research Centre, Dr. Reddy's Laboratories, and GE Healthcare, among others. Read More

What formulation types are analyzed in the India radiopharmaceuticals market?

The market analysis covers injectable, oral, and topical formulation types. Read More

India Radiopharmaceuticals Market

ID: MRFR/Pharma/42208-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

India Radiopharmaceuticals Market Research Report By Type (Diagnostic, Therapeutic) and By Application (Neurology, Cardiology, Oncology, Others) - Growth & Industry Forecast 2025 To 2035

English

India Radiopharmaceuticals Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Billion)
  1. 4.1.1 Oncology
  2. 4.1.2 Cardiology
  3. 4.1.3 Neurology
  4. 4.1.4 Thyroid
  5. 4.1.5 Infection Imaging
2. 4.2 Healthcare, BY End Use (USD Billion)
  1. 4.2.1 Hospitals
  2. 4.2.2 Diagnostic Centers
  3. 4.2.3 Research Institutions
  4. 4.2.4 Pharmaceutical Companies
3. 4.3 Healthcare, BY Type (USD Billion)
  1. 4.3.1 Diagnostic Radiopharmaceuticals
  2. 4.3.2 Therapeutic Radiopharmaceuticals
  3. 4.3.3 Radioisotopes
  4. 4.3.4 Radiopharmaceutical Generators
4. 4.4 Healthcare, BY Distribution Channel (USD Billion)
  1. 4.4.1 Direct Sales
  2. 4.4.2 Distributors
  3. 4.4.3 Online Sales
5. 4.5 Healthcare, BY Formulation (USD Billion)
  1. 4.5.1 Injectable
  2. 4.5.2 Oral
  3. 4.5.3 Topical
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Bhabha Atomic Research Centre (IN)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Dr. Reddy's Laboratories (IN)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Bristol-Myers Squibb (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 GE Healthcare (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Siemens Healthineers (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Elekta (SE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Lantheus Medical Imaging (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Cardinal Health (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 INDIA MARKET ANALYSIS BY APPLICATION
3. 6.3 INDIA MARKET ANALYSIS BY END USE
4. 6.4 INDIA MARKET ANALYSIS BY TYPE
5. 6.5 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6. 6.6 INDIA MARKET ANALYSIS BY FORMULATION
7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF HEALTHCARE
10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
13. 6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
14. 6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
15. 6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
16. 6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
17. 6.17 HEALTHCARE, BY TYPE, 2024 (% SHARE)
18. 6.18 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
19. 6.19 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
20. 6.20 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
21. 6.21 HEALTHCARE, BY FORMULATION, 2024 (% SHARE)
22. 6.22 HEALTHCARE, BY FORMULATION, 2024 TO 2035 (USD Billion)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
  2. 7.2.2 BY END USE, 2026-2035 (USD Billion)
  3. 7.2.3 BY TYPE, 2026-2035 (USD Billion)
  4. 7.2.4 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Billion)
  5. 7.2.5 BY FORMULATION, 2026-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

India Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2026-2035)

Oncology
Cardiology
Neurology
Thyroid
Infection Imaging

Healthcare By End Use (USD Billion, 2026-2035)

Hospitals
Diagnostic Centers
Research Institutions
Pharmaceutical Companies

Healthcare By Type (USD Billion, 2026-2035)

Diagnostic Radiopharmaceuticals
Therapeutic Radiopharmaceuticals
Radioisotopes
Radiopharmaceutical Generators

Healthcare By Distribution Channel (USD Billion, 2026-2035)

Direct Sales
Distributors
Online Sales

Healthcare By Formulation (USD Billion, 2026-2035)

Injectable
Oral
Topical

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”